R26-CAG-LSL-hPLA2R1-IRES-EGFP
Nomenclature
C57BL/6Smoc-Gt(ROSA)26Sorem(CAG-LSL-hPLA2R1-IRES-EGFP)Smoc
Cat. NO.
NM-KI-220264
Strain State
Repository Live
Gene Summary
Gene Symbol
Gt(ROSA)26Sor
Model Description
Validation Data
Fig.1 Mice overexpressing hPLA2R1 exhibited slower body weight gain and increased mortality (n=12~20/group).
Fig.2 Urinary biochemical results.
hPLA2R1-overexpressing mice exhibited urinary biochemical abnormalities starting at 4 weeks of age (n=7/group).
Fig.3 Blood biochemical results.
hPLA2R1-overexpressing mice exhibited blood biochemical abnormalities starting at 4 or 6 weeks of age. (n=7/group).
Fig.4 Immunofluorescence staining of hPLA2R1 in the kidney. hPLA2R1(HO)/NPHS2-Cre+ mice showed sustained PLA2R1 expression.
Fig.5 Immunofluorescence staining of mIgG (green) and lamin A/C (red) in the kidney.
Overall, hPLA2R1-overexpressing mice exhibited increased IgG deposition in the kidney and primarily localized along the glomerular basement membrane.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
